156 related articles for article (PubMed ID: 2005672)
21. [Morbidity and mortality of diabetic patients on dialysis in a 10-year program: value of combined treatment].
Coronel F; Hortal L; Horcajo P; Naranjo P; del Pozo C; Torrente J; Barrientos A
Med Clin (Barc); 1989 Jan; 92(1):10-4. PubMed ID: 2716373
[TBL] [Abstract][Full Text] [Related]
22. Peritoneal dialysis in diabetics. Optimal insulin therapy on CAPD: intraperitoneal versus subcutaneous treatment.
Scarpioni L; Ballocchi S; Scarpioni R; Cristinelli L
Perit Dial Int; 1996; 16 Suppl 1():S275-8. PubMed ID: 8728206
[No Abstract] [Full Text] [Related]
23. CAPD in end stage patients with renal disease due to diabetes mellitus--an update.
Tzamaloukas AH; Yuan ZY; Balaskas E; Oreopoulos DG
Adv Perit Dial; 1992; 8():185-91. PubMed ID: 1361783
[TBL] [Abstract][Full Text] [Related]
24. Peritoneal dialysis in diabetic end-stage renal disease.
Khanna R; Oreopoulos DG
J Diabet Complications; 1989; 3(1):12-7. PubMed ID: 2523400
[TBL] [Abstract][Full Text] [Related]
25. Improvement of glycemic control by CAPD with intraperitoneal insulin in a child with IDDM and ESRD.
Flynn JT; Kershaw DB; Sedman AB; Smoyer WE; Bunchman TE
Adv Perit Dial; 1998; 14():265-8. PubMed ID: 10649738
[TBL] [Abstract][Full Text] [Related]
26. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
Tuzcu A; Bahceci M; Yilmaz ME; Turgut C; Kara IH
Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
[TBL] [Abstract][Full Text] [Related]
27. End-state renal failure in diabetic nephropathy: pathophysiology and treatment.
Schmitz O; Hansen HE; Orskov H; Mogensen CE; Posborg Petersen V
Blood Purif; 1985; 3(1-3):120-39. PubMed ID: 3913447
[TBL] [Abstract][Full Text] [Related]
28. Continuous ambulatory peritoneal dialysis (CAPD) in patients with diabetic nephropathy.
Kemperman FA; van Leusen R; van Liebergen FJ; Oosting J; Boeschoten EW; Struijk DG; Krediet RT; Arisz L
Neth J Med; 1991 Jun; 38(5-6):236-45. PubMed ID: 1922596
[TBL] [Abstract][Full Text] [Related]
29. Clinical aspects of continuous ambulatory and continuous cyclic peritoneal dialysis in diabetic patients.
Rottembourg J; Issad B; Allouache M; Baumelou A; Deray G; Jacobs C
Perit Dial Int; 1989; 9(4):289-94. PubMed ID: 2488384
[TBL] [Abstract][Full Text] [Related]
30. Continuous ambulatory peritoneal dialysis (CAPD) in diabetic patients with end-stage renal failure in Hong Kong.
Chan MK; Lam SS; Chiu KW
J Diabet Complications; 1987; 1(1):11-5. PubMed ID: 2968989
[TBL] [Abstract][Full Text] [Related]
31. Outcome of young and elderly diabetic patients on ambulatory peritoneal dialysis: the experience of a community hospital in Puerto Rico.
Joglar F; Saade M
P R Health Sci J; 1996 Jun; 15(2):85-90. PubMed ID: 8936611
[TBL] [Abstract][Full Text] [Related]
32. The effect of insulin delivery route on lipoproteins in type I diabetic patients on CAPD.
Nevalainen PI; Lahtela JT; Mustonen J; Taskinen MR; Pasternack A
Perit Dial Int; 1999; 19(2):148-53. PubMed ID: 10357186
[TBL] [Abstract][Full Text] [Related]
33. Hepatic subcapsular steatosis as a complication associated with intraperitoneal insulin treatment in diabetic peritoneal dialysis patients.
Torun D; Oguzkurt L; Sezer S; Zumrutdal A; Singan M; Adam FU; Ozdemir FN; Haberal M
Perit Dial Int; 2005; 25(6):596-600. PubMed ID: 16411528
[TBL] [Abstract][Full Text] [Related]
34. Insulin resistance in dialysis versus non dialysis end stage renal disease patients without diabetes.
Satirapoj B; Supasyndh O; Phantana-Angkul P; Ruangkanchanasetr P; Nata N; Chaiprasert A; Kanjanakul I; Choovichian P
J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S87-93. PubMed ID: 22043573
[TBL] [Abstract][Full Text] [Related]
35. CAPD is a first class treatment: results of an eight-year experience with a comparison of patient and method survival in CAPD and hemodialysis.
Maiorca R; Cancarini G; Manili L; Brunori G; Camerini C; Strada A; Feller P
Clin Nephrol; 1988; 30 Suppl 1():S3-7. PubMed ID: 3180531
[TBL] [Abstract][Full Text] [Related]
36. Ten years experience of CAPD in diabetics: comparison of results with non-diabetics. Italian Cooperative Peritoneal Dialysis Study Group.
Viglino G; Cancarini GC; Catizone L; Cocchi R; De Vecchi A; Lupo A; Salomone M; Segoloni GP; Giangrande A
Nephrol Dial Transplant; 1994; 9(10):1443-8. PubMed ID: 7816258
[TBL] [Abstract][Full Text] [Related]
37. Subcutaneous and intraperitoneal insulin therapy in diabetic patients on CAPD.
Nevalainen PI; Lahtela JT; Mustonen J; Pasternack A
Perit Dial Int; 1996; 16 Suppl 1():S288-91. PubMed ID: 8728209
[TBL] [Abstract][Full Text] [Related]
38. No increased risk for peritonitis by insulin injected into peritoneal dialysis solution bag through Coloplast.
Wikdahl AM; Granbom L; Stegmayr BG
ANNA J; 1997 Aug; 24(4):401-6; discussion 407-8. PubMed ID: 9325691
[TBL] [Abstract][Full Text] [Related]
39. [Treatment of chronic renal insufficiency in the diabetic by dialysis and transplantation].
Legrain M; Rottembourg J; Jacobs C
Diabete Metab; 1985 Feb; 11(1):51-69. PubMed ID: 3884405
[TBL] [Abstract][Full Text] [Related]
40. Peritonitis in type 2 diabetes mellitus due to Ochrobactrum anthropi complicating automated peritoneal dialysis.
Sepe V; Esposito P; Sacco L; Ceci A; Magrassi A; Negri MT; Libetta C; Dal Canton A
Acta Diabetol; 2010 Dec; 47(4):341-4. PubMed ID: 20563608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
